TransMedics Group (TMDX) Competitors

$127.28
-5.37 (-4.05%)
(As of 05/7/2024 ET)

TMDX vs. ITGR, LIVN, CNMD, SLNO, INMD, MASI, ALPN, SEM, IMVT, and PRGO

Should you be buying TransMedics Group stock or one of its competitors? The main competitors of TransMedics Group include Integer (ITGR), LivaNova (LIVN), CONMED (CNMD), Soleno Therapeutics (SLNO), InMode (INMD), Masimo (MASI), Alpine Immune Sciences (ALPN), Select Medical (SEM), Immunovant (IMVT), and Perrigo (PRGO). These companies are all part of the "medical" sector.

TransMedics Group vs.

TransMedics Group (NASDAQ:TMDX) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, community ranking, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

TransMedics Group has a beta of 1.87, indicating that its share price is 87% more volatile than the S&P 500. Comparatively, Integer has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500.

Integer received 288 more outperform votes than TransMedics Group when rated by MarketBeat users. Likewise, 63.39% of users gave Integer an outperform vote while only 54.78% of users gave TransMedics Group an outperform vote.

CompanyUnderperformOutperform
TransMedics GroupOutperform Votes
86
54.78%
Underperform Votes
71
45.22%
IntegerOutperform Votes
374
63.39%
Underperform Votes
216
36.61%

In the previous week, TransMedics Group had 39 more articles in the media than Integer. MarketBeat recorded 49 mentions for TransMedics Group and 10 mentions for Integer. Integer's average media sentiment score of 0.95 beat TransMedics Group's score of 0.55 indicating that Integer is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
11 Very Positive mention(s)
8 Positive mention(s)
13 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
7 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Integer has a net margin of 6.01% compared to TransMedics Group's net margin of -3.43%. Integer's return on equity of 11.25% beat TransMedics Group's return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group-3.43% 7.95% 1.61%
Integer 6.01%11.25%5.69%

99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 7.0% of TransMedics Group shares are held by company insiders. Comparatively, 2.0% of Integer shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

TransMedics Group currently has a consensus target price of $119.00, suggesting a potential downside of 6.51%. Integer has a consensus target price of $120.50, suggesting a potential upside of 6.57%. Given Integer's higher possible upside, analysts clearly believe Integer is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88
Integer
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

Integer has higher revenue and earnings than TransMedics Group. TransMedics Group is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$241.62M17.35-$25.03M-$0.34-374.35
Integer$1.60B2.37$90.65M$2.8939.12

Summary

Integer beats TransMedics Group on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMDX vs. The Competition

MetricTransMedics GroupElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$4.19B$3.20B$4.97B$7.79B
Dividend YieldN/A1.67%5.35%3.96%
P/E Ratio-374.3510.39169.4919.42
Price / Sales17.3561.832,401.0581.17
Price / Cash899.2066.1633.8028.60
Price / Book30.303.994.974.42
Net Income-$25.03M$87.99M$104.02M$217.17M
7 Day Performance35.22%6.38%3.10%2.77%
1 Month Performance49.67%-3.17%-2.86%-2.00%
1 Year Performance71.95%5.21%3.83%8.89%

TransMedics Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
1.9727 of 5 stars
$113.07
+1.2%
$120.50
+6.6%
+37.5%$3.79B$1.60B39.1210,500
LIVN
LivaNova
0.8035 of 5 stars
$63.12
+0.8%
$66.20
+4.9%
+32.9%$3.42B$1.15B-105.202,900Earnings Report
CNMD
CONMED
4.9785 of 5 stars
$71.65
+1.3%
$107.86
+50.5%
-42.8%$2.21B$1.24B27.454,000Analyst Forecast
Positive News
SLNO
Soleno Therapeutics
3.4343 of 5 stars
$46.80
+1.9%
$55.60
+18.8%
+1,106.2%$1.56BN/A-15.7633Upcoming Earnings
INMD
InMode
3.6406 of 5 stars
$18.50
-0.8%
$32.80
+77.3%
-45.1%$1.55B$492.05M8.77581
MASI
Masimo
3.4914 of 5 stars
$136.00
-1.4%
$137.43
+1.1%
-27.6%$7.20B$2.05B90.075,200News Coverage
High Trading Volume
ALPN
Alpine Immune Sciences
1.5991 of 5 stars
$64.64
+0.1%
$50.33
-22.1%
+774.7%$4.24B$58.88M-101.00142Upcoming Earnings
SEM
Select Medical
4.4663 of 5 stars
$32.74
+2.0%
$34.80
+6.3%
+6.5%$4.26B$6.66B15.5954,600Dividend Announcement
Analyst Forecast
IMVT
Immunovant
3.1 of 5 stars
$29.58
-0.3%
$48.00
+62.3%
+54.1%$4.30BN/A-16.08164News Coverage
PRGO
Perrigo
4.9595 of 5 stars
$30.15
-9.8%
$40.67
+34.9%
-15.6%$4.09B$4.66B-301.509,140Earnings Report
Dividend Announcement
News Coverage
Gap Down
High Trading Volume

Related Companies and Tools

This page (NASDAQ:TMDX) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners